Consensus report: clinical recommendations for the prevention and management of the nocebo effect in biosimilar-treated IBD patients

0 avis

Consensus report: clinical recommendations for the prevention and management of the nocebo effect in biosimilar-treated IBD patients

Archive ouverte

Edité par CCSD -

International audience. The nocebo effect is a negative effect of a pharmacological or nonpharmacological medical treatment that is induced by patients' expectations, and that is unrelated to the physiological action of the treatment. The nocebo effect can negatively affect treatment outcomes.

Langue: en

Indexation

Consulter en ligne

Consulter le document

Suggestions

Du même auteur

Multidisciplinary management of the nocebo effect in biosimilar-treated IBD patients: Results of a workshop from the NOCE-BIO consensus group

Archive ouverte | D’amico, Ferdinando | CCSD

International audience

I-CARE, a European Prospective Cohort Study Assessing Safety and Effectiveness of Biologics in Inflammatory Bowel Disease

Archive ouverte | Peyrin-Biroulet, Laurent | CCSD

International audience. There is a need to evaluate the benefit-risk ratio of current therapies in inflammatory bowel disease (IBD) patients to provide the best quality of care. The primary objective of I-CARE (IBD ...

Rediscovering histology: what is new in endoscopy for inflammatory bowel disease?

Archive ouverte | Solitano, Virginia | CCSD

International audience. The potential of endoscopic evaluation in the management of inflammatory bowel diseases (IBD) has undoubtedly grown over the last few years. When dealing with IBD patients, histological remis...

Chargement des enrichissements...